p-Index From 2021 - 2026
8.564
P-Index
This Author published in this journals
All Journal International Journal of Public Health Science (IJPHS) SAINS MEDIKA : JURNAL KEDOKTERAN DAN KESEHATAN Jurnal Ilmiah Farmasi Jurnal Kebijakan Kesehatan Indonesia Pharmaciana: Jurnal Kefarmasian Indonesian Journal of Pharmaceutical Science and Technology Jurnal Farmasi Klinik Indonesia Jurnal Ilmu Farmasi dan Farmasi Klinik (Journal of Pharmaceutical Science and Clinical Pharmacy) Pharmacon MPI (Media Pharmaceutica Indonesiana) INDONESIAN JOURNAL OF PHARMACY Acta Pharmaceutica Indonesia UNEJ e-Proceeding Journal of Islamic Pharmacy JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA The Indonesian Biomedical Journal Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Jurnal Penelitian Kesehatan Suara Forikes Jurnal Surya Medika Jurnal Wiyata : Penelitian Sains dan Kesehatan JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Majalah Farmaseutik Pharmasipha Jurnal Farmasi Medica (Pharmacy Medical Journal) PMJ Media Ilmu Kesehatan JSFK (Jurnal Sains Farmasi & Klinis) JFL : Jurnal Farmasi Lampung JPSCR : Journal of Pharmaceutical Science and Clinical Research PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Jurnal Endurance: Kajian Ilmiah Problema Kesehatan Jurnal Farmasi Indonesia Oceana Biomedicina Journal JFIOnline JURNAL MEDIA KESEHATAN PREPOTIF : Jurnal Kesehatan Masyarakat Jurnal Aisyah : Jurnal Ilmu Kesehatan Journal of Pharmaceutical and Health Research Jurnal Insan Farmasi Indonesia Jurnal Farmasi dan Sains Indonesia (JFSI) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Media Farmasi Indonesia Jurnal Farmasi Sains dan Praktis Jurnal Ilmiah Kesmas-IJ (Indonesia Jaya) Riset Informasi Kesehatan Journal of Health Economic and Policy Research (JHEPR) Academic Hospital Journal Kartika : Jurnal Ilmiah Farmasi Jurnal Ilmiah Multidisiplin Keilmuan Mandira Cendikia (JIMK-MC) Journal of Tropical Pharmacy and Chemistry Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan Indonesian Journal of Pharmacology and Therapy Strada Jurnal Ilmiah Kesehatan (SJIK) Jurnal Farmasi Sains dan Terapan (Journal of Pharmacy Science and Practice)
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : JFIOnline

ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN INSULIN DIBANDINGKAN KOMBINASI INSULIN-METFORMIN PADA PASIEN DIABETES MELITUS TIPE 2 Primadiamanti, Annisa; Andayani, Tri Murti
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol 4, No 3 (2009)
Publisher : Indonesian Research Gateway

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The use of metformin in insulin therapy hopefully could increase effectiveness of type 2 diabetes treatment equal with the expenditure. Non experimental research was conducted to investigate cost-effectiveness of insulin use and insulin-metormin combination. Data was taken prospectively from baseline until month 3. The measurable cost was direct medical cost which covered cost of antidiabetic drugs, cost of complication drugs, doctor’s fee, and cost of laboratory checkup. The measurable effectiveness of therapy was reduction of FPG and HbA1c level. ACER (average cost-effectiveness ratio) was calculated based on cost and effectiveness ratio in both groups. ICER (incremental cost-effectiveness ratio) was calculated based on difference of cost and effectiveness ratio in both groups. Results showed FPG level reduction in insulin group and insulin-metformin combination consecutively was 25,05% and 1,03%. Increase of HbA1c level in insulin group and insulin-metformin combination consecutively was 6,21% and 1,87%. Based on HbA1c level reduction, ACER value in insulin group and insulin-metformin combination consecutively was Rp -37.617,00 and Rp -161.729,00, ICER value was Rp 15.860,00. From the results it can be concluded that insulin-metformin combination was more cost-effective than insulin in maintaining HbA1c level. ABSTRAK Penelitian ini dirancang untuk mengetahui efektivitas biaya pada pasien DM tipe 2 yang menggunakan insulin dan kombinasi insulin-metformin. Data diambil secara prospektif dari baseline hingga bulan ke-3. Analisis efektivitas biaya dilakukan dengan perspektif ASKES. Komponen biaya yang diukur adalah biaya medik langsung, mencakup biaya antidiabetik, biaya komplikasi, biaya kunjungan ke klinik dan biaya pemeriksaan laboratorium. Efektivitas terapi yang diukur adalah penurunan kadar GDP dan HbA1c. ACER (average cost-effectiveness ratio) dihitung berdasarkan rasio biaya dan efektivitas terapi pada kedua kelompok terapi. ICER (incremental cost-effectiveness ratio) dihitung berdasarkan rasio antara selisih biaya dan efektivitas terapi pada kedua kelompok terapi. Hasil penelitian menunjukkan penurunan kadar GDP pada kelompok insulin dan kombinasi insulin-metformin berurutan adalah 25,05% dan 1,03%. Peningkatan kadar HbA1c pada kelompok insulin dan kombinasi insulin-metformin berurutan adalah 6,21% dan 1,87%. Berdasarkan penurunan kadar HbA1c, nilai ACER pada kelompok insulin dan kombinasi insulin-metformin berurutan adalah Rp -37.617,00 dan Rp -161.729,00, nilai ICER adalah Rp15.860,00. Berdasarkan hasil penelitian dapat disimpulkan bahwa kombinasi insulin-metformin lebih cost-effective dalam mempertahankan kadar HbA1c.
ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN INSULIN DIBANDINGKAN KOMBINASI INSULIN-METFORMIN PADA PASIEN DIABETES MELITUS TIPE 2 Primadiamanti, Annisa; Andayani, Tri Murti
Jurnal Farmasi Indonesia Vol 4, No 3 (2009)
Publisher : Jurnal Farmasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfi.v4i3.21

Abstract

The use of metformin in insulin therapy hopefully could increase effectiveness of type 2 diabetes treatment equal with the expenditure. Non experimental research was conducted to investigate cost-effectiveness of insulin use and insulin-metormin combination. Data was taken prospectively from baseline until month 3. The measurable cost was direct medical cost which covered cost of antidiabetic drugs, cost of complication drugs, doctorâ??s fee, and cost of laboratory checkup. The measurable effectiveness of therapy was reduction of FPG and HbA1c level. ACER (average cost-effectiveness ratio) was calculated based on cost and effectiveness ratio in both groups. ICER (incremental cost-effectiveness ratio) was calculated based on difference of cost and effectiveness ratio in both groups. Results showed FPG level reduction in insulin group and insulin-metformin combination consecutively was 25,05% and 1,03%. Increase of HbA1c level in insulin group and insulin-metformin combination consecutively was 6,21% and 1,87%. Based on HbA1c level reduction, ACER value in insulin group and insulin-metformin combination consecutively was Rp -37.617,00 and Rp -161.729,00, ICER value was Rp 15.860,00. From the results it can be concluded that insulin-metformin combination was more cost-effective than insulin in maintaining HbA1c level. ABSTRAK Penelitian ini dirancang untuk mengetahui efektivitas biaya pada pasien DM tipe 2 yang menggunakan insulin dan kombinasi insulin-metformin. Data diambil secara prospektif dari baseline hingga bulan ke-3. Analisis efektivitas biaya dilakukan dengan perspektif ASKES. Komponen biaya yang diukur adalah biaya medik langsung, mencakup biaya antidiabetik, biaya komplikasi, biaya kunjungan ke klinik dan biaya pemeriksaan laboratorium. Efektivitas terapi yang diukur adalah penurunan kadar GDP dan HbA1c. ACER (average cost-effectiveness ratio) dihitung berdasarkan rasio biaya dan efektivitas terapi pada kedua kelompok terapi. ICER (incremental cost-effectiveness ratio) dihitung berdasarkan rasio antara selisih biaya dan efektivitas terapi pada kedua kelompok terapi. Hasil penelitian menunjukkan penurunan kadar GDP pada kelompok insulin dan kombinasi insulin-metformin berurutan adalah 25,05% dan 1,03%. Peningkatan kadar HbA1c pada kelompok insulin dan kombinasi insulin-metformin berurutan adalah 6,21% dan 1,87%. Berdasarkan penurunan kadar HbA1c, nilai ACER pada kelompok insulin dan kombinasi insulin-metformin berurutan adalah Rp -37.617,00 dan Rp -161.729,00, nilai ICER adalah Rp15.860,00. Berdasarkan hasil penelitian dapat disimpulkan bahwa kombinasi insulin-metformin lebih cost-effective dalam mempertahankan kadar HbA1c.
Co-Authors . Inayati A.M Wara Kusharwanti Abdul Khodir Jaelani Abdul Mahmud Yumassik Achmad Fudholi Achmad Fudholi Achmad Fudholi Achmad Fudholi admaja, wika Agung Endro Nugroho Agustini, Tiara Tri Ahmad H. Asdie Ahmad Suriyadi Muslim Ahmad, Irfan Aisyah, Noor Akbar Nugraha, Akbar Akuba, Jusnita Ali Ghufron Mukti Ali Gufron Mukti Amalia Amalia Amalia Amalia Amalia Amalia Ambar Yunita Nugraheni Amelia Lorensia Anak Agung Gede Sugianthara Ani Pahriyani Aniq, Laduna Anisa Zulfa Fatihah Anna Wahyuni Widayanti Anni Anni, Anni Aqnes Budiarti Ari Dwidayati Arief Nurrochmad Arini, Yovita Dwi Arissa Dwiningrum Artemisia, Rahma Astuti, Rini Budi Atsna, Zafria Avrilya Iqoranny Susilo Ayuning Siwi, Mayang Aditya Azalea, Metty Bekti Meilani Nurcahya Belinda Arbitya Dewi Candra Eka Puspitasari Candraningrat, I Dewa Agung Ayu Diva Cecep Kusmana Chairun W Chairun W Chairun Wiedyaningsih Chinthia Sari Yusriana Desy Purnamasari Dewi, Mahmud Carica dharmika wijaya sakti Dhiyan Kusumawati Didik Setiawan Dina Fatma Alia Dinaryanti, Pratiwi Dini Okyaviani Dini, Intan Rahmania Eka Diyan Ajeng Rossetyowati Diyan Ajeng Rossetyowati Djoko Wahyono Djoko Wahyono Dwiningrum, Arissa Dyah, Ria Istamining Eka Kartika Untari Eka Tri Wulandari Elsa Zhenita, Albela Endang Suparniati Endang Suparniati, Endang Endang Yuniarti Endang Yuniarti erna prasetyaningrum Etikasari, Ria Farida Munawaroh Farida, Yeni Ferdinan Jalung Ferdinan Jalung Ferdy Firmansyah Fidiawan, Arie Firda Ridhayani Fita Rahmawati Fita Rahmawati Fitri, Elny Fredie Irijanto Fredie Irijanto Fridly Manawan Gita Mayasari Gunawan Pamudji Widodo Hafizah, Ilmi Nur Halimah Hayul Halimah Hayul Handi Mukti Fahrizal Handi Mukti Fahrizal Haninditya, Beta Hari Kusnanto Hari Kusnanto Haris, Restu Nur Hasanah Herri S. Sastramihardja Hilmy Irsyadi Hanif Hutahaean, Amsaline Vingky I Dewa Putu Pramantara I Dewa Putu Pramantara I Dewa Putu Pramantara S Ibrahim Arifin Ika Alfinnisa Majida Ika Norcahyanti Ika Purwidyaningrum IKA PUSPITA SARI Ika Puspita Sari Ika Puspitasari Ika Puspitasari Ika Puspitasari Ika Trisnawati Ika Trisnawati, Ika Ikakusumawati, Novita Dhewi Imaniar Noor Faridah Imaniar Noor Faridah Inayati Inayati Inayati, Inayati Indriyati Hadi Sulistyaningrum Ingenida Hadning Intan Rahmania Eka Dini Irfanianta Arif Setyawan Irnayanti Irnayanti Irnayanti, Irnayanti Ivanka, Luna Iwan Dwiprahasto Iwan Dwiprahasto Jaelani, Abdul Khodir Jaelani, Abdul Khodir Jaelani, Abdul Qadir Jarir At Thobari Jason Merari Peranginangin Joko Sunowo Kartika Widayati Taroeno Hariadi Kusharwanti, A.M Wara Kusumawati, Dhiyan L. Endang Budiarti, L. Endang Larasati, Laksmy Anggun Lering, Maria Nona Adriani Liliany Fatonah Lingga Ikaditya Lingga Ikaditya, Lingga Listyana, Yanverty Idda Lukman Hakim Luthfan Budi Purnomo Magistasari, Dewi Makmur, Rahmat Maranatha, Daniel Mariana Wahyudi Mariska Sri Harlianti Mariska Sri Harlianti Marlina, Ni Ketut Martodiharjo, Suwaldi Maulidia, Shofia Siza Mawaqit Makani Maya Arfania Mayasari, Gita Megawati Parmasari Metty Azalea Milda Rianty Lakoan Milda Rianty Lakoan Mohamed Izham Mohamed Ibrahim Mohammad Robikhul Ikhsan Mpila, Deby Afriani Mufarrihah Mufarrihah Mufarrihah, Mufarrihah Mukhamad Najib Mukti, Ali Gufron Mulyani, Risya Munawaroh, Farida Murni, Siti Olega Adawiyah Muslimah Muslimah Mustofa Mustofa Nafiah Adiningrum Nanang Munif Yasin Nanang Munif Yasin Natalia Gilarsih Natalia Gilarsih Nawang Wulan Nago Pitasari Neneng Ratnasari Normakiyah Novena Adi Yuhara Novia Ariani Dewi Novianti, Feby Galuh Nur Rasdianah Nurcahya, Bekti Meilani Nurifahmi, Rahmaningtyas Nuring Novita Kusumawati Nurul Adzkia Ghearizky Nurul Ambianti Nurul Hikmah Nurul Latifah Nurul Qiyaam, Nurul Nurul Safitri Nuryanti, Tety Nutrisia Aquariushinta Sayuti, Nutrisia Aquariushinta Octavia, Mega Oetari Oetari Oetari Oetari Okke Putri Shera Oktaviani, Devi Okti Ratna Mafruhah Pahriyani, Ani Pamungkas, Kumbang Nirbhaya Pande Made Desy Ratnasari Parmasari, Megawati Partini Partini Partini Partini, Partini Pramana, Facetha Intan Pratiwi, Woro Rukmi Primadiamanti, Annisa Purnamasari, Vina Purnomo, Luthfan Budi Purwoko, Agus Puspita Sari, Ika Putri Dina Mahera Laily R, Herowati Rahajeng, Bangunawati Rahayu, Asri Rahma, Nazulanita Rahmawati, Anindya Rahmawati, Fita Rahmawati, Fita Rastiti, Liza Ratnasari, Pande Made Desy Renni Simorangkir Ria Etikasari Ria Istamining Dyah Rina Triasih Riskayanti Riswaka Sudjaswadi Riyanta Aribawa Rizaldy Pinzon Rizaldy T Pinzon Rizka Humardewayanti Asdie Rizky Danang Susetyo Rizky Hidayaturahmah Rokhman, Rifqi Rukminingsih, Fef Ryan Astaruddin S, I Dewa Putu Pramantara Safnurbaiti, Dwi Putri Saharuddin, Tria Saputra Sammulia, Suci Fitriani Sampurno Sampurno Sampurno Sampurno Sampurno, Sampurno Santi Andriani Saputra, Andy Kurniawan Saputri, Erlika Sari, Maya Dwi Wulan Sari, Rafika Mutia Sarifudin, Barbara Azalya Satibi Satibi Satibi Satibi Satibi Satibi Satibi Satibi Selamet, Ni Made Dwi Antika Septiyanti, Windy Setiyaningsih, Hermawati Setyawan, Irfanianta Arif Simanullang, Raymon Siradjuddin, Ammar Sri Haryanti Starlista, Viva Sudewi Mukaromah Khoirunnisa Suffiana, Yunita Sugiyanto - Sugiyanto Sugiyanto Sukengtyas, Dyah Atmi Tri Sulistiawaty, Endang Sunarti Sunarti Supanji, Supanji Susi Ari Kristina Susi Ari Kristina Suwendar Suwendar Syahrizal Ramadhani Syaiful Katadi Tety Nuryanti Titik Nuryastuti Titik Sunarni Tri Wijayanti Tria Saputra Saharuddin Tuangrat Phodha Umi Athijah Utami, Dika Aryan Venanti, Bernadeta Setyo Vo Quang Trung widi astuti r Widiastuti Widiastuti Willi Wahyu Timur Winarni Winarni Wirawan Adikusuma Wulandari, Aprilla Ayu Yance Anas Yeni Farida Yopi Rikmasari, Yopi Yovita Dwi Arini Yusriana, Chinthia Sari Zullies Ikawati ZULLIES IKAWATI Zullies Ikawati Zullies Ikawati